JAPAN ATOMIC INDUSTRIAL FORUM, INC.

for Japanese

30 July, 2019

QST President Says New System Will Reinforce R&D on Charged Particle Therapy

On June 20, President Toshio Hirano and other representatives from Japan’s National Institute for Quantum and Radiological Science and Technology (QST) met the press to explain the FY19 reorganization of the organization into “QST 2.0,” with research on quantum life science at its core.

QST President Toshio Hirano (center)

The institute was created in April 2016 through the partial merger of its predecessor, the National Institute of Radiological Sciences (NIRS), together with the Quantum Beam Directorate and the Nuclear Fusion Directorate of the Japan Atomic Energy Agency (JAEA).

On the occasion of entering its fourth year, QST is carrying out the major structural reorganization, aiming to reinforce its R&D efforts using its next-generation charged-particle cancer therapy device, known as the quantum scalpel. It will also continue to develop human resources to work in radiation emergency medicine.

The Quantum Life Science Directorate, a new organization directly under President Hirano, will take a nationwide approach, developing organic linkages among several research bases and cross-appointing researchers from various universities to realize QST’s goals: to clarify life phenomena based on quantum theory and technology, and to promote medical development.

Expecting the new research area of quantum medical science to span “from scholarly research to innovation,” QST’s approach and commitment is to extensively return its research results to society.

Placed under the newly-established Quantum Medical Science Directorate are the National Institute of Radiological Sciences (NIRS), the Center for Advanced Radiation Emergency Medicine and the QST Hospital. In cooperation with other directorates, the NIRS, an R&D institution, will especially focus on developing the quantum scalpel, which integrates superconductivity and laser technologies, to realize a society with “no cancer deaths and healthier longevity.”

The QST Hospital, redesigned since the NIRS took it over, promotes the clinical application of research results. An International Therapy Research Center will also be newly established to accept foreign trainees in the area of charged-particle cancer therapy.

At the June 20 press conference, Managing Director Takashi Nakano of the Quantum Medical Science Directorate stressed that charged-particle cancer therapy would never be able to come into wide use with equipment at its current size.

It has been a quarter century since the Heavy Ion Medical Accelerator in Chiba (HIMAC)—the pioneering device for charged-particle cancer therapy—was first used in treatment. Nakano explained the beginnings of R&D on the quantum scalpel, which is about one-fortieth the size of HIMAC, as well as its future outlook.

Meanwhile, the equipment at Gunma University is already one-third the size of that used at HIMAC. Given, however, the expense of constructing a special building to house it, the goal is to create a device—nearing the stage in which a prototype is feasible—that can be installed in existing medical facilities.

Also at the same press conference, Toshikazu Yamashita, director of the Center for Advanced Radiation Emergency Medicine, talked about his organization’s activities. In addition to his center, he said that four similar centers have been designated by the Nuclear Regulation Authority (NRA) at the following institutions around Japan: Hirosaki University, Fukushima Medical University, Hiroshima University, and Nagasaki University.

Among the five, the NRA has designated the one located at QST as the key site, making it responsible for playing a central, guiding role. Yamashita added, though, that all five bases would cooperate with each other to build a nationwide system.

Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

SNS facebooktwitter

NPPs Map

Video

“The current situation at Fukushima Daiichi NPS” -From 3.11 toward the future- (ver, July 2019)

8 July, 2019
“The current situation at Fukushima Daiichi NPS” -From 3.11 toward the future- (ver, July 2019)09:17

Recent News

10 September, 2019
Symposium in Tokyo Looks at Taiwanese Energy Situation, and Discusses Fear and Misinformation about Foods Sourced in Fukushima
10 September, 2019
Kyushu Electric Power Files Decommissioning Plan for Genkai-2 and Seeks Change to Genkai-1 Plan, with Work on Both to Proceed Simultaneously
4 September, 2019
White Paper on Nuclear Energy Features Decommissioning, Accumulation of Technology as “Great Assets” for the Future
29 August, 2019
TEPCO to Decide Fate of Kashiwazaki Kariwa Units 1 to 5 Five Years after Restarting Units 6 and 7
29 August, 2019
TEPCO, Chubu Electric Power, Hitachi, Toshiba Considering Joint Business for BWRs
16 August, 2019
Two-day International Forum on Decommissioning Fukushima Daiichi Focuses on Coexistence and Co-prosperity with Local Communities
16 August, 2019
Proponents for Above-ground HLW Management Lose in Chiba University Debate
9 August, 2019
NRA Exchanges Views with President Sakamoto of RFS, Which Pledges to Make Its Utmost Efforts
9 August, 2019
IRID Symposium Held in Fukushima, with Students Explaining Their Research on Fuel Debris Removal
8 August, 2019
TEPCO Decides to Decommission All Four Fukushima Daini Units
▲TOP